Predict your next investment

Cyprium Partners company logo
Private Equity
FINANCE | Investment Firms & Funds
cyprium.com

See what CB Insights has to offer

Investments

41

Portfolio Exits

14

Funds

3

Partners & Customers

1

About Cyprium Partners

Cyprium Partners, formerly Key Principal Partners, is a private equity firm focused primarily on non-control (minority ownership) investments. Cyprium utilizes a combination of subordinated debt, preferred stock and/or common stock to enable privately-held businesses, entrepreneurs and management teams to achieve their financial and/or strategic objectives. With offices in Cleveland and New York, the firm invests $10 million to $60 million per transaction in US and Canadian companies that have $8 million or more of EBITDA. Cyprium Investment Partners was formed in June 2011.

Cyprium Partners Headquarters Location

200 Public Square Suite 2020

Cleveland, Ohio, 44114,

United States

216-453-4500

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Cyprium Partners Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Cyprium Partners Rank

Latest Cyprium Partners News

08:07 ET Cyprium Completes Minority Investment in Remprex

Jul 21, 2021

News provided by Share this article Remprex (PRNewsfoto/Cyprium Partners) CLEVELAND, July 21, 2021 /PRNewswire/ -- Cyprium Partners, a private equity firm focused on non-controlling investments in the middle-market, has completed a new subordinated debt and preferred equity investment in Remprex to recapitalize the company's balance sheet and fund the acquisition of Technical Services International, Inc. ("TSI"). Remprex, headquartered outside Chicago, Illinois, provides terminal operations and access control solutions to Class I intermodal rail terminals and distribution centers across North America. Access control solutions include installation, maintenance and operation of automated gate systems and related technology infrastructure. Terminal operations include loading, unloading, and management of intermodal containers and automotive units. "The Remprex acquisition of TSI is consistent with the company's strategy of becoming more meaningful to the Class I railroads," said Cindy Babitt, a Partner with Cyprium. "The acquisition of TSI complements the numerous offerings Remprex already provides to the Class I intermodal yards and the combined entity should provide for better more efficient service. We are proud to support Remprex in this acquisition." "We are very pleased to have Cyprium as a financial partner to Remprex", said Remy Diebes, CEO of the company. Mr. Diebes continued to say, "Remprex is a growth company. In addition to providing capital to support our growth we look forward to working collaboratively with the team at Cyprium Partners and expect that we will benefit greatly from their insight and perspective as we continue to build Remprex." About Cyprium Partners  Cyprium Partners is a private equity and mezzanine firm focused on non-controlling investments in profitable middle-market companies, allowing company owners and their management teams to retain a controlling interest in their businesses. Cyprium provides common equity, preferred stock, subordinated debt, or any combination thereof, offering flexibility and increasing the certainty of close. With offices in Cleveland, New York, and Chicago, the firm invests $10 million to $60 million per transaction in U.S. and Canadian companies with $8 million or more of EBITDA. Since the late 90s, our team has invested over $1.7 billion in 94 platform investments. Learn more about Cyprium Partners at cyprium.com . Contact Karen Heise

Cyprium Partners Investments

41 Investments

Cyprium Partners has made 41 investments. Their latest investment was in D.P. Nicoli as part of their Debt on May 5, 2022.

CBI Logo

Cyprium Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/24/2022

Debt

D.P. Nicoli

$12M

Yes

1

9/8/2021

Debt

Ironwood

$30M

Yes

1

7/21/2021

Private Equity

Remprex

Yes

1

12/3/2020

Private Equity

Subscribe to see more

Subscribe to see more

10

10/29/2020

Debt

Subscribe to see more

Subscribe to see more

10

Date

5/24/2022

9/8/2021

7/21/2021

12/3/2020

10/29/2020

Round

Debt

Debt

Private Equity

Private Equity

Debt

Company

D.P. Nicoli

Ironwood

Remprex

Subscribe to see more

Subscribe to see more

Amount

$12M

$30M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

1

10

10

Cyprium Partners Portfolio Exits

14 Portfolio Exits

Cyprium Partners has 14 portfolio exits. Their latest portfolio exit was Rental Equipment Investment Corp on January 06, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/6/2022

Acq - Fin

$99M

1

6/12/2017

Merger

$99M

1

6/1/2016

Acq - Fin

$99M

1

8/19/2015

Merger

Subscribe to see more

$99M

Subscribe to see more

10

12/5/2014

Acq - Fin - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/6/2022

6/12/2017

6/1/2016

8/19/2015

12/5/2014

Exit

Acq - Fin

Merger

Acq - Fin

Merger

Acq - Fin - II

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

1

1

10

10

Cyprium Partners Acquisitions

12 Acquisitions

Cyprium Partners acquired 12 companies. Their latest acquisition was Terry Tree Service on September 21, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

9/21/2021

$99M

Acq - Fin

1

9/8/2021

Debt

$99M

$30M

Acq - Fin

2

4/28/2020

Debt

$99M

$3.5M

Acq - Fin

1

5/14/2019

Subscribe to see more

$99M

Subscribe to see more

10

9/16/2016

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/21/2021

9/8/2021

4/28/2020

5/14/2019

9/16/2016

Investment Stage

Debt

Debt

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$30M

$3.5M

Note

Acq - Fin

Acq - Fin

Acq - Fin

Subscribe to see more

Subscribe to see more

Sources

1

2

1

10

10

Cyprium Partners Fund History

3 Fund Histories

Cyprium Partners has 3 funds, including Cyprium Investors V.

Closing Date

Fund

Fund Type

Status

Amount

Sources

4/22/2020

Cyprium Investors V

Mezzanine (Third-Party)

Closed

$445M

3

3/10/2020

Cyprium Parallel Investors V

$99M

10

1/7/2015

Cyprium Investors IV

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

4/22/2020

3/10/2020

1/7/2015

Fund

Cyprium Investors V

Cyprium Parallel Investors V

Cyprium Investors IV

Fund Type

Mezzanine (Third-Party)

Subscribe to see more

Status

Closed

Subscribe to see more

Amount

$445M

$99M

$99M

Sources

3

10

10

Cyprium Partners Partners & Customers

1 Partners and customers

Cyprium Partners has 1 strategic partners and customers. Cyprium Partners recently partnered with National Institute of Child Health and Human Development on March 3, 2017.

Date

Type

Business Partner

Country

News Snippet

Sources

3/14/2017

Licensor

United States

Fortress Biotech Forms New Subsidiary, Cyprium Therapeutics, Inc., to Develop Novel Therapies for Menkes Disease and Related Copper Metabolism Disorders

In addition , Cyprium and Eunice Kennedy Shriver National Institute of Child Health and Human Development have entered into a worldwide , exclusive license agreement to develop and commercialize adeno-associated virus - based gene therapy , called AAV-ATP7A , to deliver working copies of the copper transporter that is defective in Menkes patients , and to be used in combination with CUTX-101 .

1

Date

3/14/2017

Type

Licensor

Business Partner

Country

United States

News Snippet

Fortress Biotech Forms New Subsidiary, Cyprium Therapeutics, Inc., to Develop Novel Therapies for Menkes Disease and Related Copper Metabolism Disorders

In addition , Cyprium and Eunice Kennedy Shriver National Institute of Child Health and Human Development have entered into a worldwide , exclusive license agreement to develop and commercialize adeno-associated virus - based gene therapy , called AAV-ATP7A , to deliver working copies of the copper transporter that is defective in Menkes patients , and to be used in combination with CUTX-101 .

Sources

1

Cyprium Partners Team

1 Team Member

Cyprium Partners has 1 team member, including former Chief Financial Officer, Dennis Wagner.

Name

Work History

Title

Status

Dennis Wagner

Chief Financial Officer

Former

Name

Dennis Wagner

Work History

Title

Chief Financial Officer

Status

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.